Dr. Turcotte is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2450 Riverside Ave
Minneapolis, MN 55454Phone+1 612-365-8100Fax+1 612-365-8101
Summary
- Dr. Lucie Turcotte is a pediatric hematologist/oncologist in Minneapolis, MN and is affiliated with multiple hospitals in the area, including University of Minnesota Masonic Children's Hospital, Hennepin Healthcare, and Essentia Health. She received her medical degree from University of Minnesota Medical School and has been in practice 11 years. She is experienced in leukemia, lymphoma and cancer survivorship care.
Education & Training
- University of MinnesotaMS, Clinical Research, 2015
- University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2010 - 2013
- University of WashingtonResidency, Pediatrics, 2007 - 2010
- University of Minnesota Medical SchoolClass of 2007
- University of MinnesotaMPH, Maternal and Child Health, 2005
- University of Notre DameBS, Biological Sciences, 2002
Certifications & Licensure
- MN State Medical License 2010 - 2025
- WA State Medical License 2007 - 2010
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Clinical Excellence Honoree University of Minnesota Physicians, 2021-2023
- Top Doctor Minnesota Monthly Magazine, 2016-2023
- Order of the Eastern Star Scholar
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsChronic conditions, late mortality, and health status after childhood AML: a Childhood Cancer Survivor Study report.Lucie M Turcotte, Jillian A Whitton, Wendy M Leisenring, Rebecca M Howell, Joseph P Neglia
Blood. 2023-01-05 - 11 citationse-Cigarette Use Among Young Adult Cancer Survivors Relative to the US PopulationHelen Parsons, Patricia Jewett, Karim Thomas Sadak, Lucie M. Turcotte, Rachel Isaksson Vogel
JAMA Oncology. 2020-06-01 - 21 citationsSubsequent Neoplasms After a Primary Tumor in Individuals With Neurofibromatosis Type 1.Smita Bhatia, Yanjun Chen, F. Lennie Wong, Lindsey Hageman, Kandice Smith
Journal of Clinical Oncology. 2019-09-18
Journal Articles
- A pilot study evaluating chemotherapy tolerability for breast cancer patients who have received prior treatment and chest radiation for Hodgkin lymphomaWatson AP, Peterson B, Vogel R, Baxstrom K, Lee C, Turcotte L, Blaes A., Cancer Treatment and Research Communications, 1/1/2018
- Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantationTurcotte LM, Knight JM, Spellman S, Arora M, Wang T, Hemmer M, Verneris MR., Bone Marrow Transplantation, 1/1/2018
- Risk, risk factors and surveillance of subsequent malignant neoplasms in childhood cancer survivors: a reviewTurcotte LM, Neglia JP, Reulen RC, Ronckers C, van Leeuwen F, Morton LM, Oeffinger KC, Henderson TO., Journal of Clinical Oncology, 1/1/2018
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Socioeconomic Status Is Associated with Prognostic Factors in Childhood Acute Lymphoblastic Leukemia - Implications for Outcomes: A Report from the Children's Oncology...Lucie M Turcotte, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell TransplantationLucie M Turcotte, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Monocyte subpopulation recovery and outcomes following hematopoietic cell transplantationTurcotte LM, Cao Q, Krahn E, Curtsinger J, Yingst AM, Cooley S, Brunstein CG, MacMillan ML, Holtan SG, Wagner JE, Weisdorf DJ, Blazar BR, Miller JS, Verneris MR., American Society of Hematology Annual Meeting, San Diego, CA, 1/1/2016
- Join now to see all
Lectures
- Chronic Health Conditions and Late Mortality Among Survivors of Childhood Acute Myeloid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS)Clinically Re...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Subsequent malignant neoplasms (SMNs) among non-irradiated survivors of childhood cancer treated with chemotherapy in the Childhood Cancer Survivor Study.2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
- Mortality Following Breast Cancer in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study.1/1/2018
- Join now to see all
Press Mentions
- U of M Documents Stunning Impact of Poverty on Cell Function, TransplantsJuly 28th, 2024
- Double TroubleDecember 1st, 2021
- Clinical Challenges: Pediatric ALL in Children with ObesityJune 14th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: